Literature DB >> 12757059

Clinical indications for penetrating keratoplasty in Maharaj Nakorn Chiang Mai Hospital, 1996-1999.

Winai Chaidaroon1, Somsanguan Ausayakhun, Suphop Ngamtiphakorn, Jeradach Prasitsilp.   

Abstract

PURPOSE: To determine the leading indication for penetrating keratoplasty. MATERIAL AND
METHOD: The authors retrospectively performed a chart review of the hospital records of all patients who underwent penetrating keratoplasty at Maharaj Nakorn Chiang Mai Hospital between January 1996 and December 1999.
RESULTS: A total of 45 corneal transplants were performed. The leading indications for penetrating keratoplasty, in order of decreasing frequency, were bullous keratopathy (28.9%), corneal scar (22.2%), corneal dystrophy and degeneration (20.0%), corneal ulcer (17.8%), regraft (8.9%), and trauma (2.2%).
CONCLUSION: Bullous keratopathy was the leading indication for penetrating keratoplasty at Maharaj Nakorn Chiang Mai Hospital from 1996 to 1999, followed by corneal scar. The major cause of bullous keratopathy was associated with posterior chamber intraocular lens implantation.

Entities:  

Mesh:

Year:  2003        PMID: 12757059

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  4 in total

1.  Indications for and techniques of keratoplasty at Vietnam National Institute of Ophthalmology.

Authors:  Pham Ngoc Dong; Truong Nhu Han; Anthony J Aldave; Hoang Thi Minh Chau
Journal:  Int J Ophthalmol       Date:  2016-03-18       Impact factor: 1.779

2.  Indications of penetrating keratoplasty in southern India.

Authors:  Laxman Dasar; Chaitra Pujar; Kanwarpal Singh Gill; Madhuri Patil; Mallikarjun Salagar
Journal:  J Clin Diagn Res       Date:  2013-11-10

3.  Corneal Phaeohyphomycosis Caused by Bipolaris hawaiiensis.

Authors:  Winai Chaidaroon; Sumet Supalaset; Napaporn Tananuvat; Nongnuch Vanittanakom
Journal:  Case Rep Ophthalmol       Date:  2016-07-21

4.  Indications and techniques employed for keratoplasty in the Eastern province of Saudi Arabia: 6 years of experience.

Authors:  Khalid M Al-Arfai; Sanaa A Yassin; Ali S Al-Beshri; Mohanna Y Al-Jindan; Elham R Al-Tamimi
Journal:  Ann Saudi Med       Date:  2015 Sep-Oct       Impact factor: 1.526

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.